Literature DB >> 6066698

Erythroblastosis fetalis and hyperbilirubinemia. A five-year follow-up with neurological, psychological, and audiological evaluation.

W H Johnston, V Angara, R Baumal, W A Hawke, R H Johnson, S Keet, M Wood.   

Abstract

Entities:  

Mesh:

Year:  1967        PMID: 6066698

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  8 in total

Review 1.  Use of evoked potentials in preterm neonates.

Authors:  M J Taylor; E Saliba; J Laugier
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

2.  Chronic Auditory Toxicity in Late Preterm and Term Infants With Significant Hyperbilirubinemia.

Authors:  Sanjiv B Amin; Satish Saluja; Arvind Saili; Mark Orlando; Hongyue Wang; Nirupama Laroia; Asha Agarwal
Journal:  Pediatrics       Date:  2017-10       Impact factor: 7.124

3.  Phototherapy in neonatal jaundice.

Authors: 
Journal:  Br Med J       Date:  1972-04-08

4.  Exchange transfusion in the newborn. A four-year experience.

Authors:  M Singh; S K Mittal
Journal:  Indian J Pediatr       Date:  1969-05       Impact factor: 1.967

5.  Hyperintense globus pallidus on T1-weighted MR imaging in acute kernicterus: is it common or rare?

Authors:  Abdulhakim Coskun; Ali Yikilmaz; Sefer Kumandas; Okkes Ibrahim Karahan; Mustafa Akcakus; Ali Manav
Journal:  Eur Radiol       Date:  2004-11-24       Impact factor: 5.315

Review 6.  Management of severe hyperbilirubinemia in the cholestatic neonate: a review and an approach.

Authors:  Jon F Watchko; M Jeffrey Maisels
Journal:  J Perinatol       Date:  2022-02-10       Impact factor: 3.225

7.  Sequelae of neonatal jaundice.

Authors:  P Culley; J Powell; J Waterhouse; B Wood
Journal:  Br Med J       Date:  1970-08-15

Review 8.  Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders.

Authors:  Sanjiv B Amin; Tristram Smith; Geralyn Timler
Journal:  Pediatr Res       Date:  2018-10-23       Impact factor: 3.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.